title: Epidermal growth factor receptor as a biomarker for cervical cancer.
abstract: This review focuses on the different modes of expression of the epidermal growth factor receptor (EGFR). All methods used to assess EGFR expression are critically analyzed and insights into the use of inhibitors of EGFR for treatment of cervical cancer are discussed. Currently, expression of EGFR as a biomarker for prognosis or for treatment of cervical cancer is not defined for clinical use.
authors.affiliation: Department of Internal Medicine, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM 87131, USA.
authors.forename: T
authors.initials: T
authors.lastname: Soonthornthum
authors.forename: H
authors.initials: H
authors.lastname: Arias-Pulido
authors.forename: N
authors.initials: N
authors.lastname: Joste
authors.forename: L
authors.initials: L
authors.lastname: Lomo
authors.forename: C
authors.initials: C
authors.lastname: Muller
authors.forename: T
authors.initials: T
authors.lastname: Rutledge
authors.forename: C
authors.initials: C
authors.lastname: Verschraegen
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000201:enzymology*
chemical_list: D014408:Biomarkers, Tumor; D066246:ErbB Receptors